CRISPR-TIL for metastatic melanoma

Status

Withdrawn

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-510417-25-00

Acronym

MM2318

Enrollment

Registered

2024-04-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced or metastatic melanoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Denmark

None listed

Source: EU CTIS · Data processed: Feb 4, 2026